Latest Insider Transactions at Perrigo CO PLC (PRGO)
This section provides a real-time view of insider transactions for Perrigo CO PLC (PRGO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PERRIGO Co plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PERRIGO Co plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 17
2023
|
Geoffrey M. Parker Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,778
+28.58%
|
$248,896
$32.86 P/Share
|
|
May 17
2023
|
Donal O'Connor Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,734
-15.14%
|
$119,488
$32.86 P/Share
|
|
May 17
2023
|
Donal O'Connor Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,778
+23.98%
|
$248,896
$32.86 P/Share
|
|
May 17
2023
|
Jeffrey B Kindler Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,734
-16.83%
|
$119,488
$32.86 P/Share
|
|
May 17
2023
|
Jeffrey B Kindler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,778
+25.96%
|
$248,896
$32.86 P/Share
|
|
May 17
2023
|
Katherine C. Doyle Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,734
-26.41%
|
$119,488
$32.86 P/Share
|
|
May 17
2023
|
Katherine C. Doyle Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,778
+35.49%
|
$248,896
$32.86 P/Share
|
|
May 17
2023
|
Orlando D Ashford Director |
SELL
Payment of exercise price or tax liability
|
Direct |
4,668
-31.74%
|
$149,376
$32.86 P/Share
|
|
May 17
2023
|
Orlando D Ashford Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,723
+39.8%
|
$311,136
$32.86 P/Share
|
|
May 11
2023
|
Murray S Kessler CEO |
SELL
Open market or private sale
|
Direct |
197,646
-98.67%
|
$6,917,610
$35.75 P/Share
|
|
Mar 13
2023
|
Thomas Farrington EVP and CIO |
SELL
Open market or private sale
|
Direct |
3,723
-30.22%
|
$130,305
$35.58 P/Share
|
|
Mar 10
2023
|
James E Dillard Iii EVP & President CSCA |
SELL
Open market or private sale
|
Direct |
9,000
-26.37%
|
$315,000
$35.7 P/Share
|
|
Mar 08
2023
|
Ronald Craig Janish EVP, Gbl Ops & SC & CTO |
SELL
Open market or private sale
|
Direct |
4,500
-18.23%
|
$162,000
$36.92 P/Share
|
|
Mar 07
2023
|
Alison Ives EVP & Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
510
-6.22%
|
$18,870
$37.71 P/Share
|
|
Mar 07
2023
|
Alison Ives EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,746
+17.55%
|
$64,602
$37.71 P/Share
|
|
Mar 07
2023
|
James E Dillard Iii EVP & President CSCA |
SELL
Payment of exercise price or tax liability
|
Direct |
2,498
-6.82%
|
$92,426
$37.71 P/Share
|
|
Mar 07
2023
|
James E Dillard Iii EVP & President CSCA |
BUY
Exercise of conversion of derivative security
|
Direct |
5,537
+13.13%
|
$204,869
$37.71 P/Share
|
|
Mar 07
2023
|
Grainne Quinn EVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,170
-7.68%
|
$43,290
$37.71 P/Share
|
|
Mar 07
2023
|
Grainne Quinn EVP, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+12.87%
|
$83,250
$37.71 P/Share
|
|
Mar 07
2023
|
Robert Willis EVP & CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,125
-7.66%
|
$41,625
$37.71 P/Share
|
|
Mar 07
2023
|
Robert Willis EVP & CHRO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,163
+12.84%
|
$80,031
$37.71 P/Share
|
|
Mar 07
2023
|
Murray S Kessler CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,850
-5.59%
|
$438,450
$37.71 P/Share
|
|
Mar 07
2023
|
Murray S Kessler CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
26,994
+11.29%
|
$998,778
$37.71 P/Share
|
|
Mar 07
2023
|
Svend Andersen EVP & President CHCI |
BUY
Exercise of conversion of derivative security
|
Direct |
5,468
+7.67%
|
$202,316
$37.71 P/Share
|
|
Mar 07
2023
|
Ronald Craig Janish EVP, Gbl Ops & SC & CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,099
-4.26%
|
$40,663
$37.71 P/Share
|
|
Mar 07
2023
|
Ronald Craig Janish EVP, Gbl Ops & SC & CTO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,942
+10.24%
|
$108,854
$37.71 P/Share
|
|
Mar 07
2023
|
Thomas Farrington EVP and CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,159
-15.04%
|
$42,883
$37.71 P/Share
|
|
Mar 07
2023
|
Thomas Farrington EVP and CIO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,406
+23.8%
|
$89,022
$37.71 P/Share
|
|
Mar 06
2023
|
Geoffrey M. Parker Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+23.95%
|
$190,000
$38.05 P/Share
|
|
Mar 03
2023
|
Thomas Farrington EVP and CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,148
-22.51%
|
$157,624
$38.75 P/Share
|
|
Mar 03
2023
|
Thomas Farrington EVP and CIO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,954
+21.36%
|
$112,252
$38.75 P/Share
|
|
Mar 03
2023
|
Thomas Farrington EVP and CIO |
BUY
Grant, award, or other acquisition
|
Direct |
6,493
+50.0%
|
$246,734
$38.75 P/Share
|
|
Mar 03
2023
|
Svend Andersen EVP & President CHCI |
BUY
Exercise of conversion of derivative security
|
Direct |
5,951
+4.81%
|
$226,138
$38.75 P/Share
|
|
Mar 03
2023
|
Svend Andersen EVP & President CHCI |
BUY
Grant, award, or other acquisition
|
Direct |
13,081
+19.38%
|
$497,078
$38.75 P/Share
|
|
Mar 03
2023
|
James E Dillard Iii EVP & President CSCA |
SELL
Payment of exercise price or tax liability
|
Direct |
6,799
-6.94%
|
$258,362
$38.75 P/Share
|
|
Mar 03
2023
|
James E Dillard Iii EVP & President CSCA |
BUY
Exercise of conversion of derivative security
|
Direct |
4,675
+6.9%
|
$177,650
$38.75 P/Share
|
|
Mar 03
2023
|
James E Dillard Iii EVP & President CSCA |
BUY
Grant, award, or other acquisition
|
Direct |
10,277
+23.63%
|
$390,526
$38.75 P/Share
|
|
Mar 03
2023
|
Ronald Craig Janish EVP, Gbl Ops & SC & CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,392
-6.25%
|
$166,896
$38.75 P/Share
|
|
Mar 03
2023
|
Ronald Craig Janish EVP, Gbl Ops & SC & CTO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,613
+7.29%
|
$137,294
$38.75 P/Share
|
|
Mar 03
2023
|
Ronald Craig Janish EVP, Gbl Ops & SC & CTO |
BUY
Grant, award, or other acquisition
|
Direct |
7,941
+25.16%
|
$301,758
$38.75 P/Share
|
|
Mar 03
2023
|
Murray S Kessler CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
40,685
-7.11%
|
$1,546,030
$38.75 P/Share
|
|
Mar 03
2023
|
Murray S Kessler CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
32,944
+8.13%
|
$1,251,872
$38.75 P/Share
|
|
Mar 03
2023
|
Murray S Kessler CEO |
BUY
Grant, award, or other acquisition
|
Direct |
72,410
+27.29%
|
$2,751,580
$38.75 P/Share
|
|
Mar 03
2023
|
Alison Ives EVP & Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,186
-6.32%
|
$45,068
$38.75 P/Share
|
|
Mar 03
2023
|
Alison Ives EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,208
+13.81%
|
$83,904
$38.75 P/Share
|
|
Mar 03
2023
|
Alison Ives EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
677
+11.08%
|
$25,726
$38.75 P/Share
|
|
Mar 03
2023
|
Robert Willis EVP & CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,713
-9.09%
|
$141,094
$38.75 P/Share
|
|
Mar 03
2023
|
Robert Willis EVP & CHRO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,231
+7.99%
|
$84,778
$38.75 P/Share
|
|
Mar 03
2023
|
Robert Willis EVP & CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
4,905
+25.95%
|
$186,390
$38.75 P/Share
|
|
Mar 03
2023
|
Grainne Quinn EVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,190
-9.88%
|
$159,220
$38.75 P/Share
|